Management of Post Nasal Drip Induced Cough
For post nasal drip induced cough, start with a first-generation antihistamine plus decongestant combination (such as dexbrompheniramine with sustained-release pseudoephedrine) taken twice daily, as this is the most effective first-line treatment regardless of whether the underlying cause is allergic or non-allergic rhinitis. 1
First-Line Treatment Algorithm
Initial Therapy
- Begin with first-generation antihistamine/decongestant combinations as they have proven superior efficacy compared to newer non-sedating antihistamines due to their anticholinergic properties 1
- Specific effective combinations include dexbrompheniramine maleate plus sustained-release pseudoephedrine sulfate, or azatadine maleate plus sustained-release pseudoephedrine sulfate 1, 2
- Most patients will see improvement in cough within days to 2 weeks of initiating therapy 1, 2
- To minimize sedation, start with once-daily dosing at bedtime for a few days before increasing to twice-daily therapy 1, 2
Treatment Duration and Expectations
- For chronic cases, continue treatment for a minimum of 3 weeks 2
- Expect common side effects including dry mouth and transient dizziness 1, 2
- Monitor for more serious side effects: insomnia, urinary retention, jitteriness, tachycardia, worsening hypertension, and increased intraocular pressure in glaucoma patients 1, 2
Cause-Specific Modifications
For Allergic Rhinitis
- Add intranasal corticosteroids (such as fluticasone 100-200 mcg daily) as first-line therapy alongside the antihistamine/decongestant combination 1, 2
- A 1-month trial of intranasal corticosteroids is recommended 3, 1, 4
- Oral leukotriene inhibitors can be added to decrease symptoms of allergic rhinitis 1, 2
- Cromolyn nasal spray is an alternative option 1, 2
For Non-Allergic Rhinitis
- First-generation antihistamine plus decongestant remains the primary treatment 1, 2
- Newer-generation antihistamines are significantly less effective for non-allergic causes and should be avoided 1, 2
- Intranasal corticosteroids may be used but are not as well-studied for this indication 4
For Chronic Sinusitis
- Treat with antibiotics effective against H. influenzae, mouth anaerobes, and S. pneumoniae for a minimum of 3 weeks 2
- Add oral antihistamine/decongestant for 3 weeks 2
- Use nasal decongestant for only 5 days (never exceed this to avoid rhinitis medicamentosa) 2
- Follow with 3 months of intranasal corticosteroids after cough resolution 2, 4
Alternative and Second-Line Options
When First-Line Fails
- Ipratropium bromide nasal spray is an effective alternative for patients who don't respond to antihistamine/decongestant combinations or have contraindications 1, 2
- Combination therapy with fluticasone nasules, ipratropium bromide, and azelastine nasal sprays for 28 days showed improvement in cough scores in an open study 5
Azelastine Nasal Spray
- Azelastine (a topical second-generation antihistamine) at 2 sprays per nostril twice daily controls postnasal drip symptoms in 78-90% of patients after 2 weeks 6
- Particularly effective for mixed rhinitis (seasonal allergic rhinitis with nonallergic triggers) 6
- Well-tolerated with only 2.3% discontinuation rate due to adverse events 6
Critical Pitfalls to Avoid
Medication Errors
- Never use topical nasal decongestants for more than 3-5 consecutive days due to risk of rhinitis medicamentosa (rebound congestion) 2
- Do not use newer-generation antihistamines as monotherapy for non-allergic postnasal drip—they are ineffective 1, 2
- Antihistamines have no role in symptomatic relief for non-atopic patients and may worsen congestion by drying nasal mucosa 2
Diagnostic Considerations
- Recognize that approximately 20% of patients have "silent" postnasal drip with no obvious symptoms yet still respond to treatment 1, 2
- Symptoms and clinical findings are not reliable discriminators for establishing postnasal drip as the cause of cough 3, 1
- A successful response to treatment directed at the upper airway is the recommended diagnostic approach 3
Treatment Sequencing
- Do not use intranasal corticosteroids as monotherapy initially for upper airway cough syndrome—they should follow or accompany combination therapy 4
- Once cough resolves with initial therapy, continue intranasal corticosteroids for 3 months to maintain symptom control and prevent recurrence 4
- Do not discontinue intranasal corticosteroids prematurely—the 3-month continuation is critical 4
Special Populations
Chronic Idiopathic Postnasal Drip
- Patients with chronic idiopathic postnasal drip (median duration 36 months) respond positively to first-generation antihistamine-decongestant medication in 71.6% of cases 7
- However, 25.9% experience symptom recurrence, particularly those with nasal stiffness or persistent symptoms 7
- Throat discomfort is the most frequently associated symptom (73.7%), while cough occurs in 30.3% 7